Because it established the tone for everything that came after, the February moment is worth revisiting. Following Anthropic’s claim that its Claude Code AI could update COBOL, the programming language that still powers IBM mainframes in major banks, insurance companies, and government agencies, shares fell 13.2% in a single session—the biggest one-day decline since 2000. The market responded appropriately because it was the kind of headline that hits IBM like a punch to the stomach. The question of whether the response was appropriate is entirely different. At the time, Brent Thill, a Jefferies analyst, contended that IBM had already begun utilizing generative AI to translate COBOL into Java and that automation and AI were far more important to the larger software revival narrative than mainframe loyalty. The market moved first, followed by inquiries. That usually occurs.

Since then, IBM has been working methodically to reconstruct the story. The business announced in late March that it would collaborate with Arm to create dual-architecture hardware for workloads involving AI and a lot of data. It had previously signed a 10-year R&D contract with ETH Zurich, the Swiss university that produced Einstein, among others, with the goal of fusing the development of quantum algorithms with artificial intelligence. These actions do not indicate a company giving up. There’s real substance behind them, not just press release optimism, but it’s still unclear if they’ll be sufficient to change sentiment in the near future.

With the January release of its most recent earnings report, IBM had a solid starting point. Revenue for the fourth quarter was $19.69 billion, above analyst estimates of $19.23 billion and up 12.2% year over year. EPS exceeded the consensus of $4.33 at $4.52. Infrastructure saw a 21% increase, while software revenue increased by 14%. According to CEO Arvind Krishna, the business is expected to grow its revenue by more than 5% in constant currency in 2026. For a business the size and age of IBM, those figures are respectable. Even so, the stock sold off, which may indicate more about the current sensitivity than the fundamentals.

The insider buying activity that is going on in the background is difficult to ignore. In late February, director Michael Miebach paid $233.33 for 434 shares. In January, director David N. Farr purchased 1,000 shares for $304. Over the previous ninety days, insiders purchased 1,484 shares totaling about $417,000. People purchasing shares with their own funds at these prices are usually not doing so out of anxiety, even though these are not huge transactions in comparison to the company’s size. They most likely have some knowledge, or at the very least, some belief, about what will happen on April 22.

That date is very important. The most obvious test to date to determine whether the software and AI momentum from Q4 was a one-quarter phenomenon or the start of something more sustainable is IBM’s first-quarter earnings release. Enterprise clients have been adopting the Watsonx platform; most recently, Tata Play Fiber in India is utilizing it to combine 25 different data sources into a single AI-ready environment. A crucial obstacle for U.S. government work has been removed with IBM’s FedRAMP authorization for 11 AI and automation products, obtained through its collaboration with Amazon Web Services. These are actual, tangible victories. On April 22, analysts will want to know if these kinds of victories are regularly translating into revenue or if they are still too dispersed to affect the overall figures.
There seems to be an unresolved tension in the way the Street is currently interpreting IBM. Evercore has an Outperform rating and a price target of $345. The current value of Royal Bank of Canada is $361.

Wedbush has an Outperform rating at $340. Then, in March, JPMorgan declared the stock neutral and lowered its target from $317 to $283. UBS changed its rating from Sell to Neutral, but it only set a target of $236, which is basically where the stock is currently trading. With an average target of about $314, the consensus comes to a Moderate Buy, suggesting significant upside. However, significant upside is meaningless if the driving force behind it is not yet apparent.

Fair points are brought up by some critics. Over the last five years, IBM’s revenue has grown at an average annual rate of just 4.1%, which is slow for a technology company during a time when the industry has typically moved quickly. Over the same time period, EPS growth averaged 5.9%, falling short of peer group norms once more. By 2026, the Confluent integration is anticipated to generate about $600 million in dilution, and the debt-to-equity ratio stands at 187%. These are genuine worries, not made-up ones. The consulting industry has been underperforming, despite the fact that it should theoretically benefit from businesses looking for assistance in implementing AI. The pinnacle of IBM’s 2019 acquisition strategy, Red Hat, saw growth cool to 10% in the fourth quarter, which is still respectable but less than the kind of figures that initially supported a $34 billion price tag.

IBM is not experiencing a crisis. It’s a company in transition once more, attempting to persuade a doubtful market that this change is real and long-lasting. That is not the first time that story has been told. The distinction now is that AI is producing actual enterprise spending, quantum computing is no longer theoretical, and IBM benefits from collaborations, government approvals, and research agreements that smaller, quicker rivals are just unable to match on a large scale. April 22 is expected to begin answering whether all of that results in a stock that is worth $314 or $236. The wait is still ongoing in Armonk.

The post IBM Stock Is Down 16% This Year — But the Insiders Buying the Dip Know Something Wall Street Doesn’t appeared first on Creative Learning Guild.

Reports that Anthropic’s AI tools could automate modernization of COBOL systems, the antiquated programming language that subtly powers government databases, banks, and insurers, caused the decline, which was the worst in over 20 years. IBM’s mainframe and COBOL ecosystem has been a reliable, nearly imperceptible source of cash flow for many years. That engine suddenly appeared vulnerable.

The irony is difficult to miss. Modern computing was shaped in part by IBM. Through Watson, it made an early investment in artificial intelligence. Currently, it is responding to AI rather than taking the lead in the eyes of investors. The stock recently closed at about $240, a significant decline from its 52-week peak of $324.90. The magnitude of the shift in sentiment is indicated by that range alone.

IBM’s longevity is practically evident in Armonk, where the company’s headquarters are surrounded by well-kept grounds and wooded hills. Workers talk about enterprise AI consulting, quantum research, and hybrid cloud while badged into glass offices. Beneath the surface, however, enormous mainframes continue to hum in data centers all over the world, handling billions of transactions every day. That legacy company is still important. A great deal.

Despite its outdated sound, COBOL powers vital infrastructure. Hundreds of billions of lines of code are thought to still be in use. IBM has been a consistent source of income due to its dominance in maintaining and updating those systems. Due to the ballast this core provided, investors have long accepted slower growth in more recent divisions. Markets move fast when AI seems capable of undermining that moat.

However, the response might have been as much emotional as logical. IBM’s most recent quarterly results were impressive, with earnings exceeding forecasts and revenue up double digits year over year. On paper, panic was not justified by the fundamentals. However, future risk, not past performance, is what markets trade on. And right now, AI seems like an erratic force that is changing everything.

The apprehension might be too early. Large-scale legacy system automation is difficult. Governments and banks are cautious. Rapid change is constrained by operational continuity, security, and compliance. Investors, however, appear to think AI technologies could threaten IBM’s reliance on consulting and maintenance services. Margin compression is possible even with partial automation.

The price-to-earnings ratio of IBM is close to 19. Considering how much more AI darlings are selling for, that’s hardly bubble territory. According to certain valuation models, a share’s intrinsic value could be more than $300. From a discounted cash flow perspective, IBM appears to be cheap. However, assumptions are what determine valuation, and assumptions are based on how disruptive AI actually becomes.

As one strolls through the financial district of Manhattan, traders can be heard discussing whether IBM is a defensive move or a dying behemoth. It’s a reasonable query. The company makes over $60 billion a year and employs close to 287,000 people worldwide. Like the plumbing in a skyscraper, it is integrated into corporate IT. It would be messy to remove it completely.

However, incumbency is not always respected by technology. After initially appearing threatened by cloud computing, Microsoft now prospers from it. Oracle struggled and then adjusted. Similar shifts have been tried by IBM, which has prioritized enterprise AI tools, invested in hybrid cloud, and acquired Red Hat. The plan makes sense. As usual, the result will depend on execution.

It seems like the market might be confusing disruption with devastation. Yes, AI can update COBOL systems. Additionally, it can speed up IBM’s own consulting business, allowing customers to switch more quickly while still using IBM’s infrastructure. New service lines could be unlocked by the same force that threatens legacy revenue. That tension hasn’t been settled yet.

Additionally, investors value IBM’s dividend, which is close to 2.8%. Reliable payouts provide consolation during erratic times. Comfort, however, is not growth. Younger investors frequently favor businesses that promise exponential growth over those with steady returns. IBM attempts to reinvent itself while preserving stability, occupying an awkward space between those worlds.

Observing the stock chart during the previous month shows notable fluctuations. decreased by almost 18% in 30 days. volatility that doesn’t imply collapse but rather uncertainty. The markets are putting IBM’s story to the test: is it an AI victim or a beneficiary? The answer might rely more on IBM’s response than on Anthropic’s announcements.

According to Arvind Krishna, enterprise AI and hybrid cloud continue to be strong tailwinds. Confidence may swiftly return if IBM can show real-world, profitable AI solutions rather than just research headlines. Reliability is important to enterprise clients. They don’t change course all at once.

Today’s IBM stock shows a business torn between two eras. It faces the speed of contemporary innovation while bearing the burden of history. It will take quarters, not days, to determine whether the recent sell-off was an overreaction or an early warning.

The post IBM Stock Plunges 11% — Is AI Finally Cracking Big Blue’s Fortress? appeared first on Creative Learning Guild.